Multiple sclerosis (MS) patients’ gut bacterial compositions differ significantly from those of healthy people, according to a global research team lead by UC San Francisco researchers, as do MS patients who are taking various pharmacological treatments. Intestinal bacteria have been linked in recent years to a variety of illnesses, not simply those affecting the gut, […]
Ublituxima shows promising results in the new Multiple Sclerosis treatment trials
An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a new clinical trial has found. Multiple Sclerosis serious disease which causes you to slowly lose control of your body and become less able to move. Those symptoms include loss of vision in an eye, loss of power […]
